Bempedoic Acid/Ezetimibe and Pravastatin Interaction

Drug interaction information between Bempedoic Acid/Ezetimibe and Pravastatin.

Bempedoic Acid/Ezetimibe and Pravastatin have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Bempedoic Acid/Ezetimibe and Pravastatin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Bempedoic Acid/Ezetimibe

ACL Inhibitor / Cholesterol Absorption Inhibitor

Drug B

Pravastatin

HMG-CoA Reductase Inhibitor (Statin)

How They Interact

This medicine can raise the levels of pravastatin in your blood, which may lead to muscle pain or weakness.

FDA Label Information

Pravastatin Clinical Impact: Concomitant use of NEXLIZET with pravastatin causes an increase in pravastatin concentration and may increase the risk of pravastatin-related myopathy [see Clinical Pharmacology (12.3) ] . Intervention: Avoid concomitant use of NEXLIZET with pravastatin greater than 40 mg. ( 7 ) Pravastatin: Avoid concomitant use of NEXLIZET with pravastatin greater than 40 mg.

Pravastatin Also Interacts With

View all Pravastatin interactions →

Frequently Asked Questions

What SPL severity band is on file for Bempedoic Acid/Ezetimibe + Pravastatin?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Pravastatin has 16 labeled pairs on file vs Bempedoic Acid/Ezetimibe's 7. In the moderate band specifically: Bempedoic Acid/Ezetimibe has 4 (also Simvastatin, Fenofibrate, Bempedoic Acid); Pravastatin has 9 (also Cyclosporine, Erythromycin, Clarithromycin, Colchicine).

What mechanism field is on file for Bempedoic Acid/Ezetimibe and Pravastatin?

This medicine can raise the levels of pravastatin in your blood, which may lead to muscle pain or weakness.

Pravastatin's labeled portfolio outnumbers Bempedoic Acid/Ezetimibe

SPL source-record counts only. This page's band is moderate · classes on file: Bempedoic Acid/Ezetimibe (ACL Inhibitor / Cholesterol Absorption Inhibitor); Pravastatin (HMG-CoA Reductase Inhibitor (Statin)).

Bempedoic Acid/Ezetimibe

0 major · 4 moderate · 3 minor · 7 total

Pravastatin

0 major · 9 moderate · 7 minor · 16 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.